Gardner Lewis Asset Management L P Exact Sciences Corp Transaction History

Gardner Lewis Asset Management L P

  • $353 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$37.9 - $104.44 $793,436 - $2.19 Million
-20,935 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$77.66 - $99.74 $359,177 - $461,297
4,625 Added 28.36%
20,935 $1.94 Million
Q3 2019

Nov 14, 2019
BUY
$90.37 - $122.49 $1.47 Million - $2 Million
16,310 New
16,310 $1.47 Million

Others Institutions Holding EXAS

# of Institutions
671
Shares Held
163M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.73B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Gardner Lewis Asset Management L P Portfolio

Follow Gardner Lewis Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gardner Lewis Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Gardner Lewis Asset Management L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email